EndoShape is in the process of raising $6.8 million in the latest reported funding round for the minimally invasive vessel occlusion devices maker.
The company has raised over $5.8 million so far from 17 unnamed investors, according to regulatory filings updated yesterday. EndoShape launched the equity funding round on June 10, 2014, adding to nearly $900,000 the company raised in January.
The device maker, headquartered in Boulder, Colo., develops minimally invasive plugs and coils for occluding blood vessels. The technologies leverage EndoShape’s proprietary "memory polymers" that the company hopes will "revolutionize minimally invasive treatment and endolumenal applications."
EndoShape won FDA clearance in November for its Medusa vascular plug, with indication for arterial and venous embolization in the peripheral vasculature.
The company has just under $1 million left to raise before closing the books on its latest funding round, according to an SEC filing. EndoShape didn’t disclose names of the 17 listed participants in the round, but previous backers include High Country Venture and Volcano Capital, according to the website.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!